Wells Fargo’s Tenax Therapeutics TENX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $45.6K | Buy |
24,139
+3,055
| +14% | +$23K | ﹤0.01% | 5557 |
|
|
2026
Q2 | $307K | Buy |
+21,084
| New | +$269K | ﹤0.01% | 4928 |
|
|
2024
Q2 | – | Sell |
-2
| Closed | -$8 | – | 7449 |
|
|
2024
Q1 | $8 | Hold |
2
| – | – | ﹤0.01% | 7336 |
|
|
2023
Q4 | $51 | Hold |
2
| – | – | ﹤0.01% | 6928 |
|
|
2023
Q3 | $48 | Hold |
2
| – | – | ﹤0.01% | 6929 |
|
|
2023
Q2 | $47 | Buy |
2
+1
| +100% | +$27 | ﹤0.01% | 7070 |
|
|
2023
Q1 | $30 | Buy |
+1
| New | +$104 | ﹤0.01% | 7263 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7185 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7353 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7476 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7798 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7796 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7510 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7429 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7364 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7014 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6892 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6813 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6786 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6441 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6606 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6562 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6565 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6565 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6518 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6462 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6446 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6493 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6443 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6334 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6320 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6417 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6407 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6440 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6508 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6356 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6404 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 6340 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 6278 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 5639 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 5919 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 5836 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 5696 |
|
Other funds holding TENX
Wells Fargo's TENX Position: Q3 2026 in Review
Wells Fargo increased its Tenax Therapeutics (TENX) stake by 14% in Q3 2026, buying an estimated $23K and bringing the position to 24,139 shares worth $45.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5557.
Wells Fargo first reported a position in TENX in Q1 2023 and has held it in 7 quarters since. The position peaked at $307K in Q2 2026. 106 funds tracked by Wall St. Rank hold TENX as of Q3 2026.
- Wells Fargo held 24,139 shares of Tenax Therapeutics worth $45.6K as of Q3 2026.
- Wells Fargo bought 3,055 Tenax Therapeutics shares in Q3 2026, an estimated $23K.
- Tenax Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #5557 holding.
- Wells Fargo first reported a position in Tenax Therapeutics in Q1 2023 and has held it in 7 quarters since.
- Wells Fargo's Tenax Therapeutics position peaked at $307K in Q2 2026.
- 106 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2026.
Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.